{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["155(10)"],"submitter":["Nelson KC"],"pubmed_abstract":["<h4>Importance</h4>To date, no concerted effort has been made to date to evaluate the literature on number-needed-to-biopsy (NNB) metrics, particularly to account for the differences in clinician type and melanoma prevalence in certain geographic locations.<h4>Objective</h4>To review and synthesize worldwide data for NNB for the diagnosis of cutaneous melanoma.<h4>Data source</h4>MEDLINE, Embase, and PubMed databases were searched for English-language articles published worldwide from January 1, 2000, to November 28, 2018.<h4>Study selection</h4>A total of 46 studies were included that addressed NNB for at least 3681 clinicians worldwide and included 455 496 biopsied tumors and 29 257 melanomas; primary care practitioner (PCP) data were only available from Australia.<h4>Data extraction and"],"journal":["JAMA dermatology"],"pagination":["1167-1174"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6624799"],"repository":["biostudies-literature"],"pubmed_title":["Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis."],"pmcid":["PMC6624799"],"pubmed_authors":["Swetter SM","Curiel-Lewandrowski C","Nelson KC","Saboda K","Chen SC"],"additional_accession":[]},"is_claimable":false,"name":"Evaluation of the Number-Needed-to-Biopsy Metric for the Diagnosis of Cutaneous Melanoma: A Systematic Review and Meta-analysis.","description":"<h4>Importance</h4>To date, no concerted effort has been made to date to evaluate the literature on number-needed-to-biopsy (NNB) metrics, particularly to account for the differences in clinician type and melanoma prevalence in certain geographic locations.<h4>Objective</h4>To review and synthesize worldwide data for NNB for the diagnosis of cutaneous melanoma.<h4>Data source</h4>MEDLINE, Embase, and PubMed databases were searched for English-language articles published worldwide from January 1, 2000, to November 28, 2018.<h4>Study selection</h4>A total of 46 studies were included that addressed NNB for at least 3681 clinicians worldwide and included 455 496 biopsied tumors and 29 257 melanomas; primary care practitioner (PCP) data were only available from Australia.<h4>Data extraction and","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Oct","modification":"2025-04-26T15:49:42.063Z","creation":"2025-04-06T14:58:05.823Z"},"accession":"S-EPMC6624799","cross_references":{"pubmed":["31290958"],"doi":["10.1001/jamadermatol.2019.1514"]}}